US Broker Ratings

Soleno Therapeutics (SLNO) Investor Outlook: Biotech Stock Poised for a Potential 170% Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a standout potential upside of 170.63%, according to recent analyst ratings. This biopharmaceutical company, headquartered in Redwood City, California, is..

Sarepta Therapeutics (SRPT) Stock Analysis: Is There a 21.77% Upside for Biotech Investors?

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on RNA-targeted therapeutics and gene therapy for rare diseases. Headquartered in..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a 55% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the Healthcare sector, has been making waves in the Medical Instruments & Supplies industry. With a market capitalization of $6.76 billion, this..

Integer Holdings Corporation (ITGR) Stock Analysis: Uncovering a 10% Potential Upside in Medical Devices

Integer Holdings Corporation (NYSE: ITGR) stands as a key player in the medical devices sector, offering a diverse portfolio of products and services. With a market capitalization of $2.94 billion,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Deep Dive into a Promising 72% Potential Upside

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, specifically within the medical devices industry. Specializing in innovative cardiac monitoring solutions, iRhythm has established itself as a..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Eyeing a 9.28% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $6.06 billion,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising 23.47% Potential Upside in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS) is swiftly carving out a significant niche in the healthcare sector with its groundbreaking genetic medicines. As a commercial-stage biotechnology company based in the United..

Incyte Corporation (INCY): Investor Outlook Reveals a 13.38% Potential Upside Amidst Robust Revenue Growth

Incyte Corporation (NASDAQ: INCY) stands out in the biotechnology sector as a formidable player, given its strategic focus on developing and commercializing innovative therapies. With a market capitalization of $19.09..

The Cooper Companies, Inc. (COO) Investor Outlook: Potential Upside of Nearly 19% Amid Strong Buy Ratings

For investors seeking opportunities in the healthcare sector, The Cooper Companies, Inc. (NYSE: COO) presents a compelling case. As a leader in the medical instruments and supplies industry, COO is..

Oscar Health, Inc. (OSCR) Stock Analysis: Exploring a Promising 11.27% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) has been making waves in the healthcare sector with its innovative approach to health insurance and technology. As a healthcare technology company, Oscar Health operates..

Viatris Inc. (VTRS) Investor Outlook: Evaluating a Stock with a 9.46% Potential Upside

Viatris Inc. (VTRS) presents an intriguing opportunity for investors looking to diversify within the healthcare sector, particularly in the realm of specialty and generic drug manufacturing. With a substantial market..

Masimo Corporation (MASI) Stock Analysis: Evaluating Growth Potential Amid Healthcare Innovation

Masimo Corporation (MASI), a prominent player in the healthcare sector, is making waves in the medical devices industry with its cutting-edge patient monitoring technologies. Headquartered in Irvine, California, Masimo is..

RadNet, Inc. (RDNT) Stock Analysis: Potential 52% Upside in Healthcare Diagnostics

RadNet, Inc. (RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, has been capturing the attention of investors with its robust growth potential and innovative offerings..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking a 209% Potential Upside in Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is creating a buzz among investors with its remarkable potential upside, estimated at 209.42%. This biopharmaceutical company, headquartered in Somerset, New Jersey, is making waves..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking a 23.31% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector, particularly in the diagnostics and research industry, should consider IDEXX Laboratories, Inc. (NASDAQ: IDXX). With a market capitalization of $48.58 billion, this American..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 21.55% Potential Upside in the Healthcare Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a pioneering player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $4.45 billion, TransMedics is making significant..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A Lucrative 6.74% Upside Amidst Robust Revenue Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a leading player in the medical devices sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 22.47% Potential Upside in the Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) presents an intriguing opportunity for investors within the healthcare sector, specifically in the field of medical devices. With a market capitalization of $1.83 billion,..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 9.59% Upside with Solid Dividend Yields

Takeda Pharmaceutical Company Limited (NYSE: TAK), a venerable giant in the healthcare sector, stands out with its impressive $56.49 billion market capitalization. Headquartered in Tokyo, Japan, Takeda has built a..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 50.91% Upside Potential Awaits Investors

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator in the biotechnology industry, is making waves with its cutting-edge treatments targeting muscle function. With a market cap of $7.39 billion, the company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds